These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26369664)

  • 21. Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.
    Patel VV; Felsen UR; Fisher M; Fazzari MJ; Ginsberg MS; Beil R; Akiyama MJ; Anastos K; Hanna DB
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):224-230. PubMed ID: 33433966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines.
    Liu P; Dillingham R; McManus K
    AIDS Res Ther; 2017; 14():25. PubMed ID: 28469696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cohort profile: Development and profile of a population-based, retrospective cohort of diagnosed people living with HIV in Ontario, Canada (Ontario HIV Laboratory Cohort).
    Liu J; Wilton J; Sullivan A; Marchand-Austin A; Rachlis B; Giles M; Light L; Sider D; Kroch AE; Gilbert M;
    BMJ Open; 2019 May; 9(5):e027325. PubMed ID: 31133591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
    Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
    J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal outcomes of HIV- infected persons re-engaged in care using a community-based re-engagement approach.
    Saafir-Callaway B; Castel AD; Lago L; Olejemeh C; Lum G; Frison L; Kharfen M
    AIDS Care; 2020 Jan; 32(1):76-82. PubMed ID: 31129991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
    Tanner Z; Lachowsky N; Ding E; Samji H; Hull M; Cescon A; Patterson S; Chia J; Leslie A; Raboud J; Loutfy M; Cooper C; Klein M; Machouf N; Tsoukas C; Montaner J; Hogg RS;
    BMC Infect Dis; 2016 Oct; 16(1):590. PubMed ID: 27769246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the definition of rurality on geographic differences in HIV outcomes in British Columbia: a retrospective cohort analysis.
    Jaworsky D; Loutfy M; Lu M; Ye M; Bratu A; Sereda P; Bayoumi A; Richardson L; Kuper A; Hogg RS;
    CMAJ Open; 2020; 8(4):E643-E650. PubMed ID: 33077535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    Katz IT; Kaplan R; Fitzmaurice G; Leone D; Bangsberg DR; Bekker LG; Orrell C
    PLoS Med; 2017 Nov; 14(11):e1002434. PubMed ID: 29136014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil.
    Cardoso SW; Luz PM; Velasque L; Torres TS; Tavares IC; Ribeiro SR; Moreira RI; Veloso VG; Moore RD; Grinsztejn B
    BMC Infect Dis; 2014 Dec; 14():699. PubMed ID: 25523385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application and validation of case-finding algorithms for identifying individuals with human immunodeficiency virus from administrative data in British Columbia, Canada.
    Nosyk B; Colley G; Yip B; Chan K; Heath K; Lima VD; Gilbert M; Hogg RS; Harrigan PR; Montaner JS;
    PLoS One; 2013; 8(1):e54416. PubMed ID: 23382898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationships Between Viral Load, Neuroimaging, and NP in Persons Living With HIV.
    Cooley SA; Navid J; Wisch JK; Boerwinkle A; Doyle J; Paul RH; Ances BM
    J Acquir Immune Defic Syndr; 2021 Jul; 87(3):985-992. PubMed ID: 33675615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy.
    Raboud J; Blitz S; Walmsley S; Thompson C; Rourke SB; Loutfy MR;
    HIV Clin Trials; 2010; 11(6):340-50. PubMed ID: 21239362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer incidence among HIV-positive women in British Columbia, Canada: Heightened risk of virus-related malignancies.
    Salters KA; Cescon A; Zhang W; Ogilvie G; Murray MC; Coldman A; Hamm J; Chiu CG; Montaner JS; Wiseman SM; Money D; Pick N; Hogg RS
    HIV Med; 2016 Mar; 17(3):188-95. PubMed ID: 26268461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of HAART and injection drug use on life expectancy of two HIV-positive cohorts in British Columbia.
    Lloyd-Smith E; Brodkin E; Wood E; Kerr T; Tyndall MW; Montaner JS; Hogg RS
    AIDS; 2006 Feb; 20(3):445-50. PubMed ID: 16439879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High levels of heterogeneity in the HIV cascade of care across different population subgroups in British Columbia, Canada.
    Lourenço L; Colley G; Nosyk B; Shopin D; Montaner JS; Lima VD;
    PLoS One; 2014; 9(12):e115277. PubMed ID: 25541682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. It's all about connection: Determinants of social support and the influence on HIV treatment interruptions among people living with HIV in British Columbia, Canada.
    Tam C; Wesseling T; Wang L; Salters K; Moore DM; Dawydiuk N; Zhu J; Grieve S; Bingham B; McLinden T; Hogg R; Barrios R
    BMC Public Health; 2023 Dec; 23(1):2524. PubMed ID: 38104090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-marketing experience with nevirapine extended release (XR) tablets: effectiveness and tolerability in a population-based cohort in British Columbia, Canada.
    Lepik KJ; Yip B; McGovern RA; Ding E; Nohpal A; Watson BE; Toy J; Akagi L; Harrigan PR; Moore DM; Hogg RS; Montaner JS; Barrios R
    Antivir Ther; 2015; 20(7):721-30. PubMed ID: 25960569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lost but not forgotten: A population-based study of mortality and care trajectories among people living with HIV who are lost to follow-up in Ontario, Canada.
    Kendall CE; Raboud J; Donelle J; Loutfy M; Rourke SB; Kroch A; Liddy C; Rosenes R; ; Burchell AN
    HIV Med; 2019 Feb; 20(2):88-98. PubMed ID: 30474908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of HIV infection and AIDS on death rates in British Columbia and Canada.
    Hogg RS; Schechter MT; Montaner JS; Goldstone I; Craib K; O'Shaughnessy MV
    CMAJ; 1994 Mar; 150(5):711-7. PubMed ID: 8313290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outpatient pharmacy care and HIV viral load response among patients on HAART.
    Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS
    AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.